Estrogen replacement therapy for depression in perimenopausal women

Journal of the College of Physicians and Surgeons Pakistan

Volumn 15, Issue 10, 2005, Pages 597-600

  Shaukat, Asma ^a,c   Arain, Tariq Mahmud ^b   Shahid, Amna ^b   Irfan, Shahid ^b   Farrukh, Soufia ^b  

^a QUAID E AZAM MEDICAL COLLEGE   (Pakistan)

^b BAHAWAL VICTORIA HOSPITAL   (Pakistan)

^c Bahawal Victoria Hospital ^*  (Pakistan)

Author keywords

Depression; Estrogen therapy; Menopause

Indexed keywords

ANTIDEPRESSANT AGENT; ESTROGEN;

ADULT; AGING; ARTICLE; BECK DEPRESSION INVENTORY; BLEEDING DISORDER; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HEALTH CARE FACILITY; HUMAN; HYPERTENSION; INVOLUTIONAL DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OPEN STUDY; OUTPATIENT DEPARTMENT; PAKISTAN; POSTMENOPAUSE; QUASI EXPERIMENTAL STUDY; RATING SCALE; REMISSION; SCORING SYSTEM; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TABLET FORMULATION; TREATMENT OUTCOME;

ADULT; DEPRESSION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; PERIMENOPAUSE; TREATMENT OUTCOME;

EID: 31744443428     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Greenberg P, Stiglin LE, Finkelstein, S, Bemdt ER. The economic burden of depression in 1990. J Clin Psychiatry 1993; 54: 405-18.
2. Keller M, Lavori P, Mueller T, Endicott J, Coryell W, Hirschfeld RM, et al. Time to recovery, chronicity and levels of psychopathology in major pathology: a 5-year prospective follow-up of 431 subjects. Arch Gen Rychiatry 1992; 49: 809-16.
3. Department of Health. NHS executive report: burdens of disease. Leeds: Department of Health 1996.
4. Sattar N, Khattak AA, Habib-ur-Rehman, Saqib MH, Khan FM. Psychological factors of mental disorders in children. Med Channel 2003; 9(2): 10-4.
5. Nemeroff CB, Krishan K, Reed D, Leder R, Beam C, Dunnick NR. Adrenal gland enlargement in major depression: a computed tomographic study. Arch Gen Psychiat 1992; 49: 384-7.
6. Bjorntorp P. Stress and cardiovascular disease. Acta Physiol Scand Suppl 1997; 640: 144-8.
7. Niaura R, Banks SM, Ward KD, Stoney CM, Spiro A 3rd, Aldwin CM, et al. Hostility and the metabolic syndrome in older males: the normative aging study. Psychosom Med 2000; 62: 7-6.
8. Burt VK, Altshuler LL, Rasgon N. Depressive symptoms in the perimenopause: prevalence, assessment, and guidelines for treatment. Harv Rev Psychiatry 1998; 6: 121-32.
9. Schmidt PJ, Rubinow DR. Menopause-related affective disorders: a justification for further study. Am J Psychiatry 1994; 148: 844-52.
10. Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Huninghake D, et al. Postmenopausal hormone therapy increases risk for venous thrombo-embolic disease: the heart and estrogen/progestin replacement. Study Ann Intern Med 2000; 132: 689-96.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: Am Psychiat Assoc 1994.
12. Wechsler D. Wechsler memory scale-revised manual. New York: Harcourt Brace Jovanovich, 1987.
13. Ostlund RE, Staten M, Kohrt WM, Schultz J, Malley M. The ratio of waist-to-hip circumference, plasma insulin level and glucose intolerance as independent predictors of HDL-2 cholesterol level in older adults. N Engl J Med 1990; 322: 229-34.
14. Grants JP, Custer PB, Thurlow J. Current technique of nutritional assessment. Surg Clin North Am 1981; 6: 437-63.
15. Denke M, Wilson JD. Assessment of nutritional status. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, (edi). Harrison's principles of internal medicine. 14th ed. New York. Mc Graw-Hill; 1998; 448-52.
16. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-9.
17. Greene JG. Constructing a standard climacteric scale. Maturitas 1998; 29: 25-31.
18. LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition:systematic review and metanalysis. JAMA 2001; 285: 1489-99.
19. Williams GV, Rao SG, Goldman-Rakic PS. The physiological role of 5-HT2A receptors in working memory. J Neurosci 2002; 22: 2843-54.
20. Moses EL, Drevets WC, Smith G, Mathis CA, Kalro BN, Butters MA, et al. Effects of estradiol and progesterone administration on human serotinin 2A receptor binding: a PET study. Biol Psychiatry 2000; 48: 854-60.
21. Kugaya A, Epperson CN, Zoghbi S, Van Dyck CH, Houy Y, Fujita M, et al. Increase in prefrontal cortex serotinin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 2003; 160: 1522-4.
22. Andrews G. Placebo response in depression: bane of research, boon to therapy. Br J Psychiatry 2001; 178: 192-4.
23. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy J. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynaecol 2000; 183: 414-20.
24. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001; 58: 529-34.
25. Morrison M. Estrogen and mood in aging women: an update. In Abstracts of the 15th annual meeting of the American Association of Geriatric Psychiatry. Bethesda, Md: AA GP, 2002.
26. Burger HG, Dudley EC, Hopper JL, Groome N, Guthrie JR. Prospectively measured levels of serum FSH, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinnol Metabol 1999; 84: 4025-30.
27. Salman M, Sadiq D. Mood variations in elderly women. Prof Med J 1996; 12; 28-32.